Chordate Medical Holding AB (OSTO:CMH) Debt-to-Equity : 0.00 (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Debt-to-Equity?

Chordate Medical Holding AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr0.00 Mil. Chordate Medical Holding AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr0.00 Mil. Chordate Medical Holding AB's Total Stockholders Equity for the quarter that ended in Sep. 2024 was kr14.99 Mil. Chordate Medical Holding AB's debt to equity for the quarter that ended in Sep. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Chordate Medical Holding AB's Debt-to-Equity or its related term are showing as below:

During the past 9 years, the highest Debt-to-Equity Ratio of Chordate Medical Holding AB was 0.21. The lowest was 0.13. And the median was 0.17.

OSTO:CMH's Debt-to-Equity is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.21
* Ranked among companies with meaningful Debt-to-Equity only.

Chordate Medical Holding AB Debt-to-Equity Historical Data

The historical data trend for Chordate Medical Holding AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Debt-to-Equity Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

Chordate Medical Holding AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Chordate Medical Holding AB's Debt-to-Equity

For the Medical Devices subindustry, Chordate Medical Holding AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Debt-to-Equity falls into.

Chordate Medical Holding AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Chordate Medical Holding AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	15.087
	=	0.00

Chordate Medical Holding AB's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	14.992
	=	0.00

Chordate Medical Holding AB (OSTO:CMH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Chordate Medical Holding AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

K1Z:Germany

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB Headlines

No Headlines